- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
CSIR-IICT, 101 Therapeutics collaborate for COVID drug trials
The agreement will be for 3 years tenure and on successful completion of the clinical trials, this drug would prove to be highly appropriate and effective in treatment of covid-19 and also help combating future pandemics.
Hyderabad: CSIR-Indian Institute of Chemical Technology (CSIR-IICT) has entered into an agreement with 101 Therapeutics Limited, Israel, to conduct clinical trials of a novel Covid-19 drug with enormous therapeutic potential.The collaboration is the result of the initiative taken by CSIR in connecting their labs working in healthcare theme with Israel’s nominated industries to explore...
Hyderabad: CSIR-Indian Institute of Chemical Technology (CSIR-IICT) has entered into an agreement with 101 Therapeutics Limited, Israel, to conduct clinical trials of a novel Covid-19 drug with enormous therapeutic potential.
Read also: Nosch Labs, CSIR-IICT ink pact for transfer of process knowhow to make anti-Covid drug 2-DG
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751